Home
About
Overview
Sharing Data
ORCID
Help
History (1)
EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
EGFR-targeted therapeutics: focus on SCCHN and NSCLC. ScientificWorldJournal. 2008 Sep 21; 8:909-19.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Bevacizumab
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Cetuximab
Clinical Trials as Topic
Combined Modality Therapy
Drug Resistance, Neoplasm
ErbB Receptors
Erlotinib Hydrochloride
Head and Neck Neoplasms
Humans
Lung Neoplasms
Protein Kinase Inhibitors
Quinazolines
authors with profiles
Ravi Salgia